Australian Clinical Labs Ltd (ASX:ACL)
A$ 2.38 -0.020 (-0.83%) Market Cap: 443.92 Mil Enterprise Value: 736.36 Mil PE Ratio: 16.76 PB Ratio: 3.03 GF Score: 56/100

Half Year 2026 Australian Clinical Labs Ltd Earnings Presentation Transcript

Feb 15, 2026 / 01:30 AM GMT
Release Date Price: A$2.24 (-7.44%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ACL.AX - Australian Clinical Labs Ltd
Half Year 2026 Australian Clinical Labs Ltd Earnings Presentation
Feb 16, 2026 / 01:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, everyone.

On behalf of ACL I'd like to start by acknowledging the traditional custodians on the land on which we meet today.

Today I'm joining you from Sydney on the lands of the Wongal and Gadigal peoples of the Eora nation.

We acknowledge the traditional custodians of country throughout Australia and the places from which our participants join us on this webinar, and their connections to land, sea, and community.

We pay our respects to their elders past and present, and extend that respect to Aboriginal and Torres Strait Islander peoples here today.

Welcome to the Investor webinar for Australia Clinical Labs Half-year Financial results.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot